Beijing, China

Kun Chen

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Kun Chen: Innovator in Liver Cancer Screening

Introduction

Kun Chen is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical technology, particularly in the early detection of liver cancer. With a total of 4 patents, his work focuses on innovative methods and tools that enhance cancer screening and diagnosis.

Latest Patents

One of Kun Chen's latest patents is a kit for early screening of liver cell cancer. This invention provides a comprehensive solution for detecting hepatocellular carcinoma, utilizing both gene marker detection reagents and protein marker detection reagents. The kit has shown effectiveness in achieving early screening of HCC, especially in community populations through prospective studies.

Another notable patent is a method of ctDNA library construction and sequencing data analysis for simultaneously detecting multiple common mutations in liver cancer. This method offers several advantages, including the simultaneous detection of various mutation forms without capturing, efficient capture of ultra-small target regions, and the ability to support 10-20 tests. The process also incorporates a DNA barcode to enhance the specificity of low-frequency mutation detection, making it a valuable tool for early screening, disease tracking, and prognosis prediction in liver cancer.

Career Highlights

Kun Chen has worked with esteemed organizations such as the Chinese Academy of Medical Sciences and Genetron Health Co., Ltd. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer detection.

Collaborations

Throughout his career, Kun Chen has collaborated with notable colleagues, including Yuchen Jiao and Chunfeng Qu. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kun Chen's innovative work in the field of liver cancer screening exemplifies the impact of dedicated research and development in medical technology. His contributions are paving the way for improved early detection methods, ultimately benefiting patient outcomes in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…